Be the new
Senior Scientist in Molecular Pharmacology
in a biotech company focused on the discovery, design and development of innovative peptide-based medicines
Zealand Pharma A/S (Zealand) is a fast-growing, fully integrated Copenhagen-based biotechnology company with a highly attractive pipeline. With one product on the market, one candidate in registration and six candidates in the clinical pipeline, Zealand is a unique success story in Danish biotech. We are passionate about improving the quality of life for patients with metabolic and gastrointestinal diseases, and other specialty or rare disease areas with significant unmet medical needs. In addition to the Søborg Headquarters, Zealand is also located in the United States in Boston (MA), Marlborough (MA), and New York (NY).
We are looking for a highly skilled and self-driven Senior Scientist to build and leverage our peptide display platform in the Department of Molecular Pharmacology. You will join a dedicated and engaging department consisting of 5 technicians and 7 academics. The department is central in the drug discovery process at Zealand by providing research projects at all stages with relevant in vitro data from in house assays and CROs.
In your position, you will play a key role in the integration of peptide display into our early-stage peptide discovery engine. As such, the position is highly interdisciplinary and besides working with academics and technicians in the department you will also collaborate closely with other relevant departments in Zealand Research.
As you will be the expert within your field you have a proven scientific track record and in-depth knowledge with peptide display platforms, e.g. phage display, mRNA display or similar, preferably from an industrial drug discovery setting. You have first hand experience with establishment of peptide display platforms, including library design, efficient execution of peptide display screens and subsequent data analysis including NGS analysis. In establishing the platforms, you will apply your expertise hands-on in the
Responsibilities includes helping us to:
The successful candidate will have most or all of the below qualifications:
- Develop and expand our molecular display capabilities
- Work with the department and CROs to identify peptide starting points for new research projects
- Create, support, and evaluate new project proposals
- Manage and supervise laboratory technicians
- Take part in or lead cross-departmental project teams to progress new drug candidates
- Support drug development from research to early clinic
- Be a key academic person in project teams as well as in the laboratory
What we offer
Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.
- A PhD degree in biochemistry, molecular biology, or protein science
- More than 5 years of research experience with molecular display methods
- Understanding of protein/peptide structure and interaction
- Interest in and flair for hands-on laboratory work
- The ability to develop and optimize methods to overcome technical barriers
- Positive attitude, drive, and the ability to work independently and as a team player
Our work environment is characterized by strong cross functional team-work, room for individual performance and development, informality and respect, high work-ethics and engagement, and fun.
At Zealand, we understand the value of a diverse workforce. As an employee, you will be part of an innovative, cross-disciplinary and cross-cultural working environment.
We offer a combined compensation package which includes a base salary, pension, bonus, and an attractive warrant program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities. To find out more about working at Zealand, visit our careers site and view our company video at:
Please apply no later than December 15, 2020.
For further information, please contact Principal Scientist Jesper M. Mathiesen at JMMathiesen@zealandpharma.com or Senior Director Jacob Fog at JFog@zealandpharma.com
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals.Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or follow Zealand on LinkedIn or Twitter @ZealandPharma.